These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 18667485)

  • 1. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis.
    Kimura K; Iwano M; Higgins DF; Yamaguchi Y; Nakatani K; Harada K; Kubo A; Akai Y; Rankin EB; Neilson EG; Haase VH; Saito Y
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1023-9. PubMed ID: 18667485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.
    Merlo A; Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Pitiot AS; Balbín M; Astudillo A; Valdés N; Scola B; Del Toro R; Méndez-Ferrer S; Piruat JI; Suarez C; Chiara MD
    Oncotarget; 2017 Jan; 8(4):6700-6717. PubMed ID: 28036268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tubular HIF-2α expression requires VHL inactivation and causes fibrosis and cysts.
    Schietke RE; Hackenbeck T; Tran M; Günther R; Klanke B; Warnecke CL; Knaup KX; Shukla D; Rosenberger C; Koesters R; Bachmann S; Betz P; Schley G; Schödel J; Willam C; Winkler T; Amann K; Eckardt KU; Maxwell P; Wiesener MS
    PLoS One; 2012; 7(1):e31034. PubMed ID: 22299048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.
    Higgins DF; Kimura K; Bernhardt WM; Shrimanker N; Akai Y; Hohenstein B; Saito Y; Johnson RS; Kretzler M; Cohen CD; Eckardt KU; Iwano M; Haase VH
    J Clin Invest; 2007 Dec; 117(12):3810-20. PubMed ID: 18037992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors.
    Mangiavini L; Merceron C; Araldi E; Khatri R; Gerard-O'Riley R; Wilson TL; Sandusky G; Abadie J; Lyons KM; Giaccia AJ; Schipani E
    Am J Pathol; 2015 Nov; 185(11):3090-101. PubMed ID: 26348575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein.
    Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C
    Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease.
    Wang J; Lu Z; Xu Z; Tian P; Miao H; Pan S; Song R; Sun X; Zhao B; Wang D; Ma Y; Song X; Zhang S; Liu L; Jiang H
    Sci Rep; 2017 Jan; 7():41038. PubMed ID: 28112200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubular deficiency of von Hippel-Lindau attenuates renal disease progression in anti-GBM glomerulonephritis.
    Theilig F; Enke AK; Scolari B; Polzin D; Bachmann S; Koesters R
    Am J Pathol; 2011 Nov; 179(5):2177-88. PubMed ID: 21925138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein.
    Lei L; Mason S; Liu D; Huang Y; Marks C; Hickey R; Jovin IS; Pypaert M; Johnson RS; Giordano FJ
    Mol Cell Biol; 2008 Jun; 28(11):3790-803. PubMed ID: 18285456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA; Ashcroft M
    Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway.
    Liu T; Zhao L; Chen W; Li Z; Hou H; Ding L; Li X
    Int J Mol Med; 2014 May; 33(5):1236-42. PubMed ID: 24549370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
    Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.
    Rankin EB; Tomaszewski JE; Haase VH
    Cancer Res; 2006 Mar; 66(5):2576-83. PubMed ID: 16510575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
    Gong K; Zhang N; Zhang K; Na Y
    Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53.
    Cho IR; Koh SS; Min HJ; Park EH; Ratakorn S; Jhun BH; Jeong SH; Yoo YH; Youn HD; Johnston RN; Chung YH
    Cancer Gene Ther; 2010 May; 17(5):365-72. PubMed ID: 20075985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation.
    Zhao D; Zheng S; Wang X; Liu H; Zhao K; Li L; Hu Y
    Oncogene; 2022 Mar; 41(13):1944-1958. PubMed ID: 35169254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
    Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
    Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
    Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.